← Back to Search

Next Day Clinic for Patient Care (NDC Trial)

N/A
Recruiting
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Admitted or being admitted to an internal medicine service
18 years of age or older
Must not have
Undergoing workup for solid organ transplant
Interstitial lung disease (including pulmonary fibrosis) (per Higher Level 7 value set)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 12 months
Awards & highlights
No Placebo-Only Group

Summary

"This trial is about a new clinic called the Next Day Clinic (NDC) that will be run by UCLA Health starting in July 2024. The clinic aims to improve patient care and safety while

Who is the study for?
The UCLA Next Day Clinic trial is for patients who visit the emergency department with conditions like diabetic foot, osteomyelitis, cellulitis, kidney issues, heart failure, pneumonia or fainting. These should be low-acuity cases that normally would require hospital admission.
What is being tested?
This study tests a new approach where instead of admitting certain patients to the hospital from the ED, they are sent home and return to a high-acuity clinic called NDC the next day. The goal is to improve care quality and cost-effectiveness.
What are the potential side effects?
Since this trial involves a healthcare service method rather than medication or medical procedures directly on patients, traditional side effects are not applicable. However, there may be risks associated with delaying immediate inpatient care.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently admitted or will be admitted to an internal medicine department.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am being evaluated for an organ transplant.
Select...
I have a lung condition like pulmonary fibrosis.
Select...
I have had a heart or lung transplant and there are concerns about how well it is working.
Select...
I am currently admitted to an intensive care unit.
Select...
I have an active cancer diagnosis.
Select...
I have high blood pressure in the arteries of my lungs.
Select...
I need a surgery that requires anesthesia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Days alive and out of hospital (DAOH)
Secondary study objectives
Cost effectiveness analysis
Financial analysis
Global health-related quality of life
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Next Day ClinicExperimental Treatment1 Intervention
Patients with even birthdays who meet inclusion criteria will be given the option to receive care in the Next Day Clinic to avoid hospitalization.
Group II: ED-initiated hospitalizationActive Control1 Intervention
Patients with odd birthdays will be routed to standard-of-care ED-initiated hospitalization pathways.

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,562 Previous Clinical Trials
10,261,281 Total Patients Enrolled
~720 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top